Markets
Security ▲ | Price | % | Buy | Sell | Target price | Potential |
---|---|---|---|---|---|---|
Enzon Pharmaceuticals |
€0.11
01.08.24 |
- | 0 | 0 | - | - |
EOS Imaging |
€2.39
04.06.21 |
- | 0 | 0 | - | - |
Epicore Bionetworks Inc |
-
- |
- | 0 | 0 | - | - |
Epigenomics AG NA |
€0.44
10.12.20 |
-4.040% | 0 | 0 | - | - |
Epizyme Inc. |
€1.43
02.12.22 |
- | 0 | 0 | - | - |
E-Play Digital Inc. |
€0.001
15.07.24 |
100.000% | 0 | 0 | - | - |
Eps Holdings Inc |
€13.61
16.09.21 |
0.250% | 0 | 0 | - | - |
Ergomed plc |
€15.16
10.11.23 |
-0.130% | 0 | 0 | - | - |
Erytech Pharma S.A. |
€0.39
15.09.23 |
-5.170% | 0 | 0 | - | - |
Esperion Therapeutis.Inc. |
€1.88
02.08.24 |
-5.600% | 16 | 1 | €10.00 | 430.926% |
ESSA Pharma Inc |
€6.80
18.08.21 |
1.490% | 0 | 0 | - | - |
Essex Bio-Technology Ltd |
€0.61
30.09.21 |
-2.420% | 0 | 0 | - | - |
EssilorLuxottica SA |
€209.50
02.08.24 |
-0.710% | 3 | 0 | €204.50 | -2.387% |
Estia Helath Ltd |
€1.83
06.12.23 |
0.550% | 0 | 0 | - | - |
E-Therapeutics Plc |
€0.091
08.05.24 |
-7.610% | 0 | 0 | - | - |
Eurobio scientific |
€24.35
01.08.24 |
35.280% | 0 | 0 | - | - |
Euromedis Groupe |
€4.40
01.08.24 |
-1.350% | 0 | 0 | - | - |
Evgen Pharma plc |
€0.001
01.08.24 |
- | 0 | 0 | - | - |
Evofem Biosciences Inc. |
€0.46
19.11.22 |
- | 0 | 0 | - | - |
Evoke Pharma Inc. |
€0.38
31.07.24 |
2.730% | 0 | 24 | - | - |
Evolent Health Inc |
€21.40
01.08.24 |
-1.830% | 0 | 0 | - | - |
Evolus Inc |
€12.60
01.08.24 |
11.500% | 11 | 0 | €22.65 | 79.792% |
Evotec SE |
€8.11
02.08.24 |
-4.330% | 4 | 3 | €10.00 | 23.381% |
Evotec SE ADR |
€4.50
22.07.24 |
5.560% | 0 | 0 | - | - |
Exact Sciences |
€52.56
02.08.24 |
-4.620% | 17 | 0 | €75.89 | 44.389% |
Exelixis Inc. |
€22.13
02.08.24 |
-1.740% | 20 | 0 | €26.01 | 17.516% |
Expedeon AG |
€1.04
02.10.19 |
2.960% | 0 | 0 | - | - |
Eyecarrot Innovations Corp |
€0.013
16.08.19 |
-12.750% | 0 | 0 | - | - |
EyeGate Pharmaceuticals Inc |
€0.15
30.08.19 |
1.310% | 0 | 0 | - | - |
EyePoint Pharmaceuticals Inc. |
€9.09
01.08.24 |
4.120% | 19 | 1 | €28.29 | 211.127% |